Susceptibility of bacteria to chemotherapeutic agents (Zürich, 1996);Die empfindlichkeit von bakterien gegen chemotherapeutika (Zürich, 1996)

Praxis

Volumn 87, Issue 12, 1998, Pages 403-412

  Wust J ^a   Zbinden, R ^b   Kayser, F H ^b  

^a Medica   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antibacterial chemotherapy; Bacteria; Bacterial resistance; Sensitivity

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFALOTIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE; OXACILLIN; PENICILLIN G; TETRACYCLINE; TICARCILLIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; CHEMOTHERAPY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LABORATORY DIAGNOSIS; REVIEW; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0032542733     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Satcher D.: Emerging infections: getting ahead of the curve. Emerging Infect. Dis. 1, 1-6, 1995.
2. Steffen R., Gutzwiller F.: Neue Infektionskrankheiten - weltweiter Alarm, weltweite Reaktion. Bulletin BAG 4-6, 1997.
3. Tenover F.C., Hughes J.M.: The challenges of emerging infectious diseases: development and spread of multiply resistant bacterial pathogens. JAMA 275, 300-304, 1996.
4. Pinner R.W., Teutsch S.M., Simonsen L., Klug L.A., Graber J.M., Clarke M.J., Berkelman R.L.: Trends in infectious diseases mortality in the United States. JAMA 275, 189-193, 1996.
5. Bartlett J.G.: Update in infectious diseases. Ann. Intern. Med. 126: 48-56, 1996.
6. Hamilton-Miller J.M.T: Living in the "post-an-tibiotic era": could the use of probiotics be an effective strategy. Clin. Microbiol. Infect. 3: 2-4, 1997.
7. Cassadewell A.: Crisis in infctious diseases: time for a new paradigm? Clin. Infect. Dis. 23: 790-794, 1996.
8. Monitoring and management of bacterial resistance to antimicrobial agents: a World Health Organization symposium. Clin. Infect. Dis. 24 (Suppl. 1), S1-S175, 1997.
9. Kayser F.H., Wüst J.: Häufigkeit der Resistenz gegen Chemotherapeutika bei Bakterien, isoliert von Praxis- und Spitalpatienten (Zürich, 1976). Schweiz. Rundsch. Med. (PRAXIS) 22, 669-675, 1977.
10. Kayser F.H., Wüst J., Munzinger J.: Empfindlichkeit von Bakterien gegen Chemotherapeutika (Zürich, 1980). Schweiz. Med. Wschr. 112, 411-418, 1982.
11. Wüst J., Kayser F.H.: Die Empfindlichkeit von Bakterien gegen Chemotherapeutika (Zürich, 1987). Schweiz. Rundsch. Med. (PRAXIS) 78, 745-750, 1989.
12. Wüst J., Kayser F.H.: Die Empfindlichkeit von Bakterien gegen Chemotherapeutika (Zürich, 1990). Schweiz Rundsch. Med. (PRAXIS) 80, 946-953, 1991.
13. Wüst J., Kayser F.H.: Die Empfindlichkeit von Bakterien gegen Chemotherapeutika (Zürich, 1993). Schweiz. Rundsch. Med. (PRAXIS) 84, 98-105, 1995.
14. Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., Yolken R.H. (eds.): Manual of Clinical Microbiology, 6th ed. American Society for Microbiology, Washington. D.C. 1995.
15. National Committee for Clinical Laboratory Standards (NCCLS): Performance standards for antimicrobial disk susceptibility tests - fifth edition. Approved Standard M2-A5. NCCLS, Villanova. PA 1993.
16. National Committee for Clinical Laboratory Standards (NCCLS): Performance standards for antimicrobial susceptibility testing. Sixth Informational Supplement. NCCLS, Villanova, PA 1995.
17. National Committee for Clinical Laboratory Standards (NCCLS): Methods for dilution antimicrobial tests for bacteria that grow aerobically - third edition. Approved Standard M7-A3. NCCLS, Villanova, PA 1993.
18. Arzneimittelkompendium der Schweiz 1997, 18. Auflage, Documed AG, Basel 1997.
19. Kayser F.H., Bille J.: In-vitro-Aktivität von Cefuroxim-Axetil gegen Erreger bakterieller Infektionen des Respirationstrakts, Schweiz. Rdsch. Med. (PRAXIS) 79, 1383-1386, 1990.
20. Wüst J., Huf E., Kayser F.H.: Antimicrobial susceptibility and serotypes of invasive Streptococcus pneumoniae in Switzerland. J. Clin. Microbiol. 33, 3159-3163, 1995.
21. Pallares R., Linares J., Vadillo M., Cabellos C., Manresa F., Viladrich P.F., Martin R., Gudiol F.: Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333. 474-480, 1995.
22. Rubinstein E., Rubinovitch B.: Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins. Infection 22, S161-S166, 1994.
23. Klugman K.P.: Management of antibiotic-resistant pneumococcal infections J. Antimicrob. Chemother. 34, 191-193, 1994.
24. Wüst J., Hardegger U.: Die Empfindlichkeit anaerober Bakterien gegen Chemotherapeutika (Zürich, 1991). Schweiz. Rundschau Med. (PRAXIS) 80, 1474-1480, 1991.
25. Mandell G.L., Douglas R.G., Bennet J.E. (eds.): Principles and Practice of Infectious Diseases, 4th ed. Churchill Livingstone, New York 1995.
26. Reese R.E., Belts R.F. (eds.): A Practical Approach to Infectious Diseases, 4th ed. Little, Brown & Co., Boston 1996.
27. Sanford J.P., Gilbert D.N., Moellering R.C., Sande M.A.: Guide to Antimicrobial Therapy, 27th ed. Antimicrobial Therapy, Inc., Dallas, Texas 1997.
28. Sanford J.P., Gilbert D.N., Moellering R.C., Sande M.A.: Guide to HIV/AIDS Therapy, 6th ed. Antimicrobial Therapy, Inc., Dallas, Texas 1997.
29. Deguchi T., Kawamura T., Yasuda M., Nakano M., Fukuda H., Kato H., Kato N., Okano Y., Kawada Y.: In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections, Antimicrob. Agents Chemother. 41, 1609-1611, 1997.
30. Centers for Disease Control: Nosocomial enterococci resistant to vancomycin - United States Morbid. Mortal. Weekly Rep. 42, 597-599, 1993.
31. Jacoby G.A.: Antimicrobial-resistant pathogens in the 1990s. Ann. Rev. Med. 47, 169-179, 1996.
32. Hughes J.M., Tenover F.C.: Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations. Clin. Infect. Dis. 24 (Suppl. 1). S131-S135, 1997.
33. Boisivon A., Thibault M., Leclerq R.: Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin. Microbiol. Infect. 3, 175-179, 1997.
34. Appelbaum P.C.: Antimicrobial resistance in Streptococcus pneumoniae - an overview. Clin. Infect. Dis. 15, 77-83, 1992.
35. Breiman R.F., Butler J.C., Tenover F.C., Elliott J.A., Facklam R.R.: Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271, 1831-1835, 1994.
36. Butler J.C., Hofmann J., Cetron M.S., Elliott J.A., Facklam R.R., Breiman R.F., Camp C., Charache P., Dern R., Jackson M., Hadley W.K., Hoppebauer J., Jacobs M.R., Schreiber J., Boxerbaum B., Menuey B.C., Tyler P.G., Monahan J., Moore H., Siegel J.D., Sherer D., Rogers P., Welch D., Fine D., Radike J., Fiore A., Alexander M., Deaver K.: The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J. Inf. Dis. 174, 986-993, 1996.
37. Oppenheim B.A.: Antibiotic resistance in Neisseria meningitidis. Clin. Infect. Dis. 24 (Suppl. 1), S98-S101, 1997.
38. Seppälä H., Nissinen A., Järvinen H., Huovinen S., Henriksson T., Herva E., Holm S.E., Jahkola M., Katilu M.L., Klaukka T., Kontiainen S., Liimatainen O., Oinonen S., Passi-Metsomaa L., Huovinen P.: Resistance to erythromycin in group A streptococci. New Engl. J. Med. 326. 292-297, 1992.
39. Seppälä H., Klaukka T., Lehtonen R., Nenonen E.: Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin. Infect. Dis. 21, 1378-1385, 1995.
40. Rowe B., Ward L.R., Threlfall E.J.: Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin. Infect. Dis. 24 (Suppl. 1), S106-S109, 1997.
41. Sack R.B., Rahman M., Yunus M., Khan E.H.: Antimicrobial resistance in organisms causing diarrheal disease. Clin. Infect. Dis. 24 (Suppl. 1), S102-S105, 1997.
42. Muñoz P., Díaz M.D., Rodríguez-Créixems M., Cercenado E., Peláez T., Bouza E.: Antimicrobial resistance of Salmonella isolates in a Spanish hospital. Antimicrob. Agents Chemother. 37, 1200-1202, 1993.
43. Kayser F.H., Morenzoni G., Santanam P.: The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 9, 810-817, 1990.
44. Felmingham D., Grüneberg R.N. and the Alexander project group: A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander project. J. Antimicrob. Chemother. 38 (Suppl. A), 1-57, 1996.
45. Doern G.V., Brueggemann A.B., Pierce G., Holley H. P., Rauch A.: Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of ß-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41, 292-297, 1997.
46. Archibald L., Phillips L., Monnet D., McGowan J.E., Tenover F., Gaynes R.: Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin. Infect. Dis. 24, 211-215, 1997.
47. Vincent J.-L., Bihari D.J., Suter P.M., Bruining H.A., White J., Nicolas-Chanoin M.-H., Wolff M., Spencer R.C., Hemmer M., for the EPIC International Advisory Committee: The prevalence of nosocomial infection in intensive care units in Europe. JAMA 274, 639-644, 1995.
48. Wüst J., Auckenthaler R., Breer C., Frei R., Heinzer I., Kamm W.: Die Empfindlichkeit von gramnegativen Bakterien auf Intensivpflegestationen gegen Chemotherapeutika. Schweiz. Med. Wschr. 124, 1695-1700, 1994.
49. Murray B.E.: The life and times of the Enterococcus. Clin. Microbiol. Rev. 3, 46-65, 1990.
50. Moellering R.C.: Emergence of Enterococcus as a significant pathogen. Clin. Infect Dis. 14, 1173-1178. 1992.
51. Leclercq R., Dutkamalen S., Brissonnoel A., Molinas C., Derlot E., Arthur M., Duval J., Conrvalin P.: Resistance of enterococci to aminoglycosides and glycopeptides. Clin. Infect. Dis. 15, 495-501, 1992.
52. Leclercq R., Courvalin P.: Resistance to glycopeptides in enterococci. Clin. Infect. Dis. 24, 545-556, 1997.
53. McDonald L.C., Kuehneri M.J., Tenover F.C., Jarvis W.R.: Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg. Infect. Dis. 3, 311-317, 1997.
54. Harbarth S., Romand J., Frei R., Auckenthaler R., Pittet D.: Transmisssion inter- et intrahospitalière de staphylococques dorés résistant à la méticilline. Schweiz. Med. Wschr. 1227, 471-478, 1997.
55. Witte W., Kresken M., Braulke C., Cuny C.: Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin. Microbiol. Infect. 3, 414-422, 1997.
56. Doern G.V., Ferraro M.J., Brueggemann A.B., Ruoff K.L.: Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40, 891-894, 1996.
57. Poyart C., Pierre C., Quesne G., Pron B., Berche P., Trieu-Cuot P.: Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob. Chemother. 41, 24-29, 1997.
58. Knapp J.S., Fox K.K., Trees D.L., Whittington W.L.: Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg. Infect. Dis. 3, 33-39, 1997.
59. kam K.M., Wong P.W., Cheung M.M., Ho N.K. Y.: Detection of quinolone-resistant Neisseria gonorrhoeae. J. Clin. Microhiol. 34, 1462-1464, 1996.
60. Gordon S.M., Carlyn C.J., Doyle L.J., Knapp C. C., Longworth D.L., Hall G.S., Washington J.A.: The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: Epidemiology and risk factors. Ann. Intern Med. 125,465-470, 1996.
61. Baquero F. and the Task Force of the General Direction for Health Planning of the Spanish Ministry of Health: Antibiotic resistance in Spain: what can be done? Clin. Infect. Dis. 23, 819-823, 1996.
62. Levy S.: Editorial response: antibiotic resistance worldwide - a Spanish task force responds. Clin. Infect. Dis. 23, 824-826, 1996.
63. Goldmann D.A., Weinstein R.A., Wenzel R.P., Tablan O.C., Duma, R.J., Gaynes R.P., Schlosser J., Martone W.J.: Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 275, 234-240, 1996.
64. Sanders W.E., Jr., Sanders C.C.: Cycling of antibiotics: an approach to circumvent resistance in spezialized units of the hospital. Clin. Microbiol. Infect. 1, 223-225, 1996.
65. Jones R.N.: The emergent needs for basic research, education, and surveillance of antimicrobial resistance: problems facing the report from the American Society for Microbiology task force on antibiotic resistance. Diagn. Microbiol. Infect. Dis. 25, 153-161, 1996.
66. Péan Y., Goldstein F.W., Guerrier M.L. and the French study group: Highlights of the French antimicrobial resistance surveillance project. Diagn. Microhiol. Infect. Dis. 25, 191-194, 1996.
67. O'Brian T.F., Stelling J.M.: WHONET: removing abstacles to the full use of information about antimicrobial resistance. Diagn. Microbiol. Infect. Dis. 25, 163-168, 1996.
68. Grüneberg R.N., Felminghum D. and the Alexander project group: Results of the Alexander project: a continuing, multicenter study of the antimicrobial suceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn. Microbiol. Infect. Dis. 25, 169-181, 1996.
69. Hohl P., Frei R., Aubry P.: In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results. Diagn. Microbiol. Infect. Dis. 14, 447-450, 1991.
70. Rice L.B., Bonomo, R.A.: Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents. In: Lorian V. (ed.) Antibiotics in laboratory medicine, 4th ed. p. 453-501. Williams and Wilkins, Baltimore 1996.